Definition

A comprehensive genotyping test that includes additional pharmacogenes beyond the standard panel (TPMT, NUDT15, DPYD, UGT1A1, HLA-B57:01, HLA-B15:02, CYP1A2, CYP3A5, COMT, SLC6A4); it provides dose/drug selection guidance in many fields, including oncology, psychiatry, cardiology and pain management.

Gene/region examined

CYP2D6, CYP2C9, CYP2C19, CYP1A2, CYP3A4

Method

Mini Sequencing

Accepted sample types

Peripheral blood (EDTA)

Inheritance

Germline/inherited.

Related Tests

Inheritance Patterns

Describes how a genetic condition is passed on within a family. There are five main patterns

Go to term →

Carrier (Heterozygous / Homozygous)

Why it matters: In autosomal recessive inheritance, when each parent is a carrier (while both appear healthy), the chance of their child being born with the disease is 25% in each

Go to term →

VUS (Variant of Uncertain Significance)

This is the situation where the test has detected a change in the DNA, but the role of this change in the development of disease is unconfirmed.

Go to term →

How to Read a Genetic Test Result (Positive / Negative / VUS)

A genetic test result falls into three main categories

Go to term →

Types of Genetic Tests

A genetic test is a type of medical test that detects changes in genes, chromosomes or proteins. Today there are more than 77,000 genetic tests available.

Go to term →